Prudential Financial’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-51,793
Closed -$256K 2516
2025
Q1
$256K Sell
51,793
-57,823
-53% -$184K ﹤0.01% 2011
2024
Q4
$322K Hold
109,616
﹤0.01% 1970
2024
Q3
$517K Buy
109,616
+1,600
+1% +$7.22K ﹤0.01% 2202
2024
Q2
$416K Buy
108,016
+300
+0.3% +$1.35K ﹤0.01% 2252
2024
Q1
$576K Sell
107,716
-14,200
-12% -$66.8K ﹤0.01% 2119
2023
Q4
$521K Buy
121,916
+1,850
+2% +$5.69K ﹤0.01% 2125
2023
Q3
$471K Buy
120,066
+20,100
+20% +$132K ﹤0.01% 2088
2023
Q2
$1.01M Buy
99,966
+46,910
+88% +$497K ﹤0.01% 1806
2023
Q1
$541K Buy
+53,056
New +$607K ﹤0.01% 2033
2022
Q3
Sell
-10,141
Closed -$134K 2721
2022
Q2
$134K Buy
+10,141
New +$138K ﹤0.01% 2504

Other funds holding TSVT

Prudential Financial's TSVT Position: Q2 2025 in Review

Prudential Financial sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 51,793 shares — an estimated $256K sold.

Prudential Financial first reported a position in TSVT in Q2 2022 and held it in 10 quarters. The position peaked at $1.01M in Q2 2023. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Prudential Financial reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Prudential Financial sold 51,793 2seventy bio shares in Q2 2025, an estimated $256K.
  • Prudential Financial first reported a position in 2seventy bio in Q2 2022 and held it in 10 quarters.
  • Prudential Financial's 2seventy bio position peaked at $1.01M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Prudential Financial's 13F filing for Q2 2025, filed 12 Aug 2025.